{"SPADE_UN_26576": {"Sequence Information": {"Peptide Name": "Temporin-SHa [G10f]", "Sequence": "FLSGIVGMLFKLF", "Sequence Length": 13, "Biological Activity": ["Anti-Gram+", "Anti-Gram-", "Anticancer", "Anti-Mammalian Cell"], "Binding Target": "1. Lipid Bilayer", "Source": "", "Gene": "", "PDB ID": "", "UniProt Entry": [{"uniprotId": "B3KYH4", "uniprotUrl": "http://www.uniprot.org/uniprot/B3KYH4", "description": "The amino acid sequence of the current peptide coincides with the part of the UniProt entry that represents a peptide precursor."}], "Literature": [{"Title": "Synthesis of Second-Generation Analogs of Temporin-SHa Peptide Having Broad-Spectrum Antibacterial and Anticancer Effects", "Pubmed ID": "39200058", "Reference": "Antibiotics (Basel). 2024;13:758", "Author": "Khan AI, Nazir S, Haque MNU, Maharjan R, Khan FA, Olleik H, Courvoisier-Dezord E, Maresca M, Shaheen F", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/39200058"}], "Mass": 1471.85, "PI": 8.75, "Net Charge": 1, "Hydrophobicity": 1.92, "Frequent Amino Acids": "FLG", "Absent Amino Acids": "ACDEHNOPQRTUWY", "Basic Residues": 1, "Acidic Residues": 0, "Hydrophobic Residues": 9, "Polar Residues": 4, "Positive Residues": 1, "Negative Residues": 0, "SPADE ID": "SPADE_UN_26576", "Similar Sequences": [{"SPADE_ID": "SPADE_UN_06989", "Similarity": 1.0, "Sequence": "MTQILLFVHVLISFLSLLLIVTNSVEIPETPCESDAECPYYSPSLYARCIDGFCTLFLS"}, {"SPADE_ID": "SPADE_UN_26576", "Similarity": 1.0, "Sequence": "FLSGIVGMLFKLF"}, {"SPADE_ID": "SPADE_UN_26578", "Similarity": 1.0, "Sequence": "FLSGIVGMLKLF"}], "Hemolytic Activity": "Human bronchial epithelial cells BEAS-2B:IC50=7.8±0.3 µM,Human Lung Fibroblasts IMR-90:IC50=14.2±0.6 µM", "Target Organism": "Acinetobacter baumannii DSM 30007(MIC=25µM),Enterobacter cloacae DSM 30054(MIC=>100µM),Escherichia coli ATCC 8739(MIC=>100µM),Helicobacter pylori ATCC 43504(MIC=3.12µM),Klebsiella pneumoniae DSM 26371(MIC=>100µM),Pseudomonas aeruginosa ATCC 9027(MIC=>100µM),Bacillus subtilis ATCC 6633(MIC=3.12µM),Enterococcus faecalis DSM 2570(MIC=3.12µM),Enterococcus faecium DSM 20477(MIC=3.12µM),Staphylococcus aureus ATCC 6538(MIC=3.12µM),Human breast adenocarcinoma MCF-7(IC50=4.±1.3µM),Human hepatocellular carcinoma HepG2(IC50=19.8±1.7µM),Human ovarian adenocarcinoma A2780(IC50=6.6±0.5µM),Human pancreatic carcinoma Mia PaCa-2(IC50=6.8±0.4µM),Human prostate adenocarcinoma PC-3(IC50=4.9±0.3µM),Human skin melanoma MNT-1(IC50=5.5±0.4µM),Human lung carcinoma A549(IC50=3.6±0.7µM)"}}}